3-Methyladenine | 3-MA;NSC 66389;3-Methyladenine, NSC 66389 | 3-甲基腺嘌呤 | Autophagy | PI3K

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]}	现货	1周咨询	- +

产品名称	C2β ↓ ↑	p110α ↓ ↑	p110β ↓ ↑	p110γ ↓ ↑	p110δ ↓ ↑	PI3K ↓ ↑	Vps34 ↓ ↑	其他靶点	纯度
A66	+ C2β, IC50: 462 nM	++ p110α, IC50: 32 nM							99%+
Taselisib	+ C2β, IC50: 292 nM	++++ PI3Kα, Ki: 0.29 nM	+++ PI3Kβ, Ki: 9.1 nM	++++ PI3Kγ, Ki: 0.97 nM	++++ PI3Kδ, Ki: 0.12 nM		+ hVps34, IC50: 374 nM		99%+
Gedatolisib		++++ PI3Kα, IC50: 0.4 nM		+++ PI3Kγ, IC50: 5.4 nM				mTOR	99%
HS-173		++++ PI3Kα , IC50: 0.8 nM							99%+
Serabelisib		+++ PI3Kα, IC50: 21 nM							99%+
GNE-477		++++ PI3Kα, IC50: 4 nM						mTOR	99%
YM-201636		+ p110α, IC50: 3.3 μM						PIKfyve	98%
AS-252424		+ PI3Kα, IC50: 935 nM		++ PI3Kγ, IC50: 33 nM					99%
Alpelisib		+++ PI3Kα, IC50: 5 nM							99%+
AS-604850		+ PI3Kα, IC50: 4.5 μM		+ PI3Kγ, IC50: 0.25 μM					99%
SF2523		++ PI3Kα, IC50: 34 nM		++ PI3Kγ, IC50: 158 nM				DNA-PK,mTOR	99%+
Inavolisib		++++ PI3K alpha, IC50: 0.038 nM							99%+
Bimiralisib		++++ PI3Kα, Kd: 1.5 nM	+++ PI3Kβ, Kd: 11 nM	++ PI3Kγ, Kd: 25 nM	++ PI3Kδ, Kd: 25 nM			mTOR	99%+
GSK1059615		++++ PI3Kα, IC50: 0.4 nM	++++ PI3Kβ, IC50: 0.6 nM	+++ PI3Kγ, IC50: 5 nM	++++ PI3Kδ, IC50: 2 nM			mTOR	98%
GSK2636771			✔						99%
Fimepinostat		+++ PI3Kα, IC50: 19 nM	++ PI3Kβ, IC50: 54 nM		++ PI3Kδ, IC50: 39 nM				99%+
VS-5584		++++ PI3Kα, IC50: 2.6 nM	+++ PI3Kβ, IC50: 21 nM	++++ PI3Kγ, IC50: 3.0 nM	++++ PI3Kδ, IC50: 2.7 nM			mTOR	98%
Dactolisib		++++ p110α1, IC50: 4 nM	++ p110β, IC50: 75 nM	+++ p110γ, IC50: 5 nM	+++ p110δ, IC50: 7 nM				98+%
PI-103		++++ p110α, IC50: 2 nM	++++ p110β, IC50: 3 nM	+++ p110γ, IC50: 15 nM	++++ p110δ, IC50: 3 nM			DNA-PK,mTOR	99%+
PI-3065			+ p110β, IC50: 1078 nM		+++ p110δ, IC50: 15 nM				99%+
Voxtalisib		++ PI3Kα, IC50: 39 nM	++ PI3Kβ, IC50: 113 nM	+++ PI3Kγ, IC50: 9 nM	++ PI3Kδ, IC50: 43 nM			DNA-PK,mTOR	99%+
AZD-8835		+++ PI3Kα, IC50: 6.2 nM	+ PI3Kβ, IC50: 431 nM	++ PI3Kγ, IC50: 90 nM	+++ PI3Kδ, IC50: 5.7 nM				99%
Pilaralisib analogue		++ PI3Kα, IC50: 39 nM	++ PI3Kβ, IC50: 36 nM	+++ PI3Kγ, IC50: 23 nM	++ PI3Kδ, IC50: 36 nM				99%+
ZSTK474		+++ PI3Kα, IC50: 16 nM	++ PI3Kβ, IC50: 44 nM	++ PI3Kγ, IC50: 49 nM	+++ PI3Kδ, IC50: 4.6 nM	++ PI3K, IC50: 37 nM			98%
AS-605240		++ PI3Kα, IC50: 60 nM	+ PI3Kβ, IC50: 270 nM	+++ PI3Kγ, IC50: 8 nM	+ PI3Kδ, IC50: 300 nM				98%
TGX-221			+++ p110β, IC50: 5 nM		++ p110δ, IC50: 0.1 μM				99%+
PF-04691502		++++ PI3Kα, Ki: 1.8 nM	++++ PI3Kβ, Ki: 2.1 nM	++++ PI3Kγ, Ki: 1.9 nM	++++ PI3Kδ, Ki: 1.6 nM			mTOR	98+%
GDC-0084		++++ PI3Kα, Ki app: 2 nM	++ PI3Kβ, Ki app: 46 nM	+++ PI3Kγ, Ki app: 10 nM	++++ PI3Kδ, Ki app: 3 nM			mTOR	99%+
Buparlisib		++ p110α, IC50: 52 nM	+ p110β, IC50: 166 nM	+ p110γ, IC50: 262 nM	++ p110δ, IC50: 116 nM		+ Vps34, IC50: 2.4 μM	mTOR	98%
LY294002		+ p110α, IC50: 0.5 μM	+ p110β, IC50: 0.97 μM		+ p110δ, IC50: 0.57 μM			DNA-PK	99%+
AZD 6482		+ PI3Kα, IC50: 870 nM	+++ PI3Kβ, IC50: 10 nM		++ PI3Kδ, IC50: 80 nM			DNA-PK	99%+
Pictilisib		++++ p110α, IC50: 3 nM	++ p110β, IC50: 33 nM	++ p110γ, IC50: 75 nM	++++ p110δ, IC50: 3 nM			mTOR	99%+
PKI-402		++++ PI3Kα, IC50: 2 nM	+++ PI3Kβ, IC50: 7 nM	+++ PI3Kγ, IC50: 16 nM	+++ PI3Kδ, IC50: 14 nM			mTOR	98%
Copanlisib		++++ PI3Kα, IC50: 0.5 nM	++++ PI3Kβ, IC50: 3.7 nM	+++ PI3Kγ, IC50: 6.4 nM	++++ PI3Kδ, IC50: 0.7 nM				99%+
Omipalisib		++++ p110α, Ki: 0.019 nM	++++ p110β, Ki: 0.13 nM	++++ p110γ, Ki: 0.06 nM	++++ p110δ, Ki: 0.024 nM				99%+
Izorlisib		+++ PI3Kα, IC50: 14 nM	++ PI3Kβ, IC50: 0.12 μM	++ PI3Kγ, IC50: 36 nM	+ PI3Kδ, IC50: 0.50 μM				99%+
AZD8186		++ PI3Kα, IC50: 35 nM	++++ PI3Kβ, IC50: 4 nM		+++ PI3Kδ, IC50: 12 nM				99%
KU-0060648		++++ PI3Kα, IC50: 4 nM	++++ PI3Kβ, IC50: 0.5 nM	+ PI3Kγ, IC50: 0.59 μM	++++ PI3Kδ, IC50: 0.1 nM			DNA-PK	98%
Apitolisib		+++ p110α, IC50: 5 nM	++ p110β, IC50: 27 nM	+++ p110γ, IC50: 14 nM	+++ p110δ, IC50: 7 nM			mTOR	98%+
CZC24832			+ PI3Kβ, IC50: 1.1 μM	++ PI3Kγ, IC50: 27 nM					98+%
BGT226 maleate		++++ PI3Kα, IC50: 4 nM	++ PI3Kβ, IC50: 63 nM	++ PI3Kγ, IC50: 38 nM				mTOR	99%+
TG 100713		++ PI3Kα, IC50: 165 nM	+ PI3Kβ, IC50: 215 nM	++ PI3Kγ, IC50: 50 nM	+++ PI3Kδ, IC50: 24 nM				98%+
PI3K-IN-1		++ PI3Kα, IC50: 39 nM	++ PI3Kβ, IC50: 113 nM	+++ PI3Kγ, IC50: 9 nM	++ PI3Kδ, IC50: 43 nM			DNA-PK,mTOR	98+%
TG100-115		+ PI3Kα, IC50: 1.3 μM	+ PI3Kβ, IC50: 1.2 μM	++ PI3Kγ, IC50: 83 nM	+ PI3Kδ, IC50: 235 nM				98%
PIK-90		+++ PI3Kα, IC50: 11 nM	+ PI3Kβ, IC50: 350 nM	+++ PI3Kγ, IC50: 18 nM	++ PI3Kδ, IC50: 58 nM				99%+
PIK-294			+ p110β, IC50: 490 nM	++ p110γ, IC50: 160 nM	+++ p110δ, IC50: 10 nM				99%+
Duvelisib			++++ PI3Kβ, Ki: 1564 pM	++ PI3Kγ, Ki: 243 pM	++++ PI3Kδ, Ki: 23 pM				99%+
GDC-0326		++++ PI3Kα, Ki: 0.2 nM	++ PI3Kβ, Ki: 26.6 nM	+++ PI3Kγ, Ki: 10.2 nM	++++ PI3Kδ, Ki: 4 nM				98%
Quercetin Dihydrate			+ PI3Kβ, IC50: 5.4 μM	+ PI3Kγ, IC50: 2.4 μM	+ PI3Kδ, IC50: 3.0 μM				95%
Quercetin			+ PI3Kβ, IC50: 5.4 μM	+ PI3Kγ, IC50: 2.4 μM	+ PI3Kδ, IC50: 3.0 μM			Sirtuin,Src,PKC	95%
Leniolisib		+ PI3Kα, IC50: 0.244 μM	+ PI3Kβ, IC50: 0.424 μM	+ PI3Kγ, IC50: 2.23 μM	+++ PI3Kδ, IC50: 0.011 μM			DNA-PK	99%+
PIK-108			✔						99%
Eganelisib				+++ PI3Kγ, IC50: 16 nM					99%+
CAY10505				✔					99%
IPI-3063					++++ p110δ, IC50: 2.5 nM				99%
Nemiralisib					++++ PI3Kδ, pKi: 9.9				99%+
PF-4989216		++++ p110α, IC50: 2 nM		++ p110γ, IC50: 65 nM	++++ p110δ, IC50: 1 nM				99%+
PIK-75 HCl		+++ p110α, IC50: 5.8 nM		++ p110γ, IC50: 76 nM	+ p110δ, IC50: 0.51 μM			DNA-PK	99%+
Tenalisib				++ PI3Kγ, IC50: 33.2 nM	++ PI3Kδ, IC50: 24.5 nM				98%
Acalisib					+++ p110δ, IC50: 14 nM				99%+
Umbralisib					+++ PI3Kδ, IC50: 22.2 nM				99%+
AMG319				+ PI3Kγ, IC50: 850 nM	+++ PI3Kδ, IC50: 18 nM				99%
IC-87114				+ PI3Kγ, IC50: 29 μM	+ PI3Kδ, IC50: 0.5 μM				99%+
Idelalisib				++ p110γ, IC50: 89 nM	++++ p110δ, IC50: 2.5 nM				98%
PIK-293				+ p110γ, IC50: 10 μM	+ p110δ, IC50: 0.24 μM				99%+
Vps34-PIK-III					+ PI3Kδ, IC50: 1.2μM		+++ Vps34, IC50: 0.018μM		99%+
GSK2292767					✔				98%
Seletalisib				+ PI3Kγ, IC50: 282 nM	+++ PI3Kδ, IC50: 12 nM				99%+
P110δ-IN-1					++++ P110δ, IC50: 0.6 nM				99%
PI3Kδ-IN-5					++++ PI3Kδ, IC50: 0.9 nM				99%
SRX3207		+ PI3K alpha, IC50: 244 nM		+ PI3K gamma, IC50: 9790 nM	+ PI3K delta, IC50: 388 nM			Syk	98%
Parsaclisib HCl					++++ PI3Kδ, IC50: 1 nM				98%
IHMT-PI3Kδ-372					+++ PI3Kδ, IC50: 14 nM				98%
Trigonelline						✔		Akt	99%+
Wortmannin						++++ PI3K, IC50: 3 nM		DNA-PK,MLCK	99%+
Samotolisib						✔		DNA-PK	99%+
GNE-317						✔			99%+
Oroxin B						✔		PTEN,Akt	99%+
NU 7026						+ PI3K, IC50: 13 μM		DNA-PK	98+%
Deguelin						✔		Akt	99%+
Ailanthone						✔		CDK,ATM/ATR,Akt	98%
Resibufogenin						✔		ROS	98%
KU-57788						+ PI3K, IC50: 5 μM		DNA-PK,mTOR	99%+
Cinobufagine						✔		Akt	99%
α-Linolenic acid						✔			97% (GC)
MTX-211						✔		EGFR	98%
PI3K/mTOR Inhibitor-2						++++ PI3K, IC50: 3.4 nM		mTOR	99%+
SPP-86						✔			99%+
(E)-Akt inhibitor-IV						✔			98%
Vps34-IN-1							++ Vps34, IC50: 25 nM		98%
SAR405							++++ Vps34, IC50: 1.2 nM		98+%
3-Methyladenine				+ PI3Kγ, IC50: 60 μM			+ Vps34, IC50: 25 μM	Autophagy	98%
Vps34-IN-4							+++ VPS34, IC50: 15 nM		98%+
Autophinib							+++ Vps34, IC50: 19 nM	Autophagy	99%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

产品名称	Autophagy ↓ ↑	其他靶点	纯度
SBI-0206965	+++ ULK1, IC50: 108 nM ULK2, IC50: 711 nM		95%
Hydroxychloroquine sulfate	✔		99%
Valproic acid sodium	✔	HDAC	97%
PFK-015	++ PFKFB3, IC50: 207 nM		99%+
MRT68921 HCl	++++ ULK1, IC50: 2.9 nM ULK2, IC50: 1.1 nM		99%+
ROC-325	✔		99%+
Autophinib	+++ Autophagy, IC50: 40 nM		99%
Lys05	✔		99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Cell Line THLE2 cells mouse primary cortical neurons COV434 cells KGN cells cardiomyocytes osteoclasts HEK293T cells Newborn mouse ovarian cells Mouse embryonic fibroblasts (MEFs)	Concentration	Treated Time	Description	References
THLE2 cells	5 mM	6 h	To inhibit autophagy and study the protective role of YAP in hepatic ischemia-reperfusion injury. Results showed that inhibition of autophagy weakened YAP-mediated cell protection, accompanied by a significant upregulation of apoptosis levels.	Chin Med J (Engl). 2024 Mar 20;137(6):657-668.
mouse primary cortical neurons	5 mM	24 h	To inhibit autophagy and evaluate its effect on neuronal survival. Results showed that 3-MA at appropriate concentrations significantly increased neuronal survival after oxygen-glucose deprivation (OGD).	J Extracell Vesicles. 2020 Oct;10(1):e12024.
COV434 cells	5 mM	24 h	Inhibited autophagy but did not significantly alleviate CDDP-induced ER stress and apoptosis	Reprod Biol Endocrinol. 2018 Sep 3;16(1):85.
KGN cells	5 mM	24 h	Inhibited autophagy but did not significantly alleviate CDDP-induced ER stress and apoptosis	Reprod Biol Endocrinol. 2018 Sep 3;16(1):85.
cardiomyocytes	10 mM	3 h	inhibited autophagy, significantly attenuated or ablated lethal toxin-induced cardiomyocyte contractile anomalies	BMC Med. 2012 Nov 7;10:134.
osteoclasts	0.5 mM	72 h	3-MA reversed the enhanced autophagy levels by DOX, indicating that enhanced autophagy was responsible for the effects of DOX.	Antioxidants (Basel). 2022 Jul 28;11(8):1476.
HEK293T cells	5 mg/mL	8 h	To investigate the effect of 3-MA on BinCARD1 degradation, it was found that 3-MA inhibited TBK1-mediated autophagic degradation of BinCARD1.	Cell Mol Immunol. 2022 Oct;19(10):1168-1184.
Newborn mouse ovarian cells	1 mM	3 days	Inhibited autophagy, leading to a decreased percentage of primordial follicles	Cell Death Dis. 2020 Sep 10;11(9):737.
Mouse embryonic fibroblasts (MEFs)	5 mM		Inhibition of autophagy, leading to increased toxicity in glucose-starved wild-type MEFs, similar to the effect of RelA inactivation.	Nat Cell Biol. 2011 Aug 28;13(10):1272-9.

Species Mice C57BL/6 male mice C57BL/6 mice C57BL/6J mice Mice C57BL/6J female mice Mice BALB/C nude mice	Animal Model Hepatic ischemia-reperfusion injury model Transverse aortic constriction (TAC)-induced cardiac hypertrophy model Middle cerebral artery occlusion (MCAO) model Cisplatin-induced premature ovarian insufficiency model TAC-induced heart failure model DOX-induced bone loss model Heterotopic transplant model of intestinal fibrosis A2780 tumor xenograft model	Administration	Dosage	Frequency	Description	References
Mice	Hepatic ischemia-reperfusion injury model	Intraperitoneal injection	15 mg/kg	Once, 1 hour before I/R model establishment	To inhibit autophagy and study the protective role of YAP in hepatic ischemia-reperfusion injury. Results showed that inhibition of autophagy weakened YAP-mediated liver protection, accompanied by a significant upregulation of apoptosis levels.	Chin Med J (Engl). 2024 Mar 20;137(6):657-668.
C57BL/6 male mice	Transverse aortic constriction (TAC)-induced cardiac hypertrophy model	Intraperitoneal injection	20 mg/kg	Once daily for 4 weeks	3-MA inhibited PKD siRNA-induced increase in autophagy and prevented the ameliorative effects of PKD siRNA on cardiac hypertrophy	Int J Biol Sci. 2017 Feb 12;13(3):276-285
C57BL/6 mice	Middle cerebral artery occlusion (MCAO) model	Intraperitoneal injection	15 mg/kg	Single injection at the beginning of reperfusion or 12 hours later	To evaluate the inhibitory effect of 3-MA on autophagy after cerebral ischemia and its impact on neuroprotection and neurological recovery. Results showed that 3-MA injection at 12 hours after reperfusion significantly reduced brain injury and improved neurological recovery.	J Extracell Vesicles. 2020 Oct;10(1):e12024.
C57BL/6J mice	Cisplatin-induced premature ovarian insufficiency model	Intraperitoneal injection	10 mg/kg	Consecutively for 7 days	Inhibiting autophagy did not significantly alleviate CDDP-induced ovarian damage and hormone dysregulation	Reprod Biol Endocrinol. 2018 Sep 3;16(1):85.
Mice	TAC-induced heart failure model	Intraperitoneal injection	15 mg/kg	Every 3 days	To inhibit autophagic induction and evaluate its effect on TAC-induced heart failure	JACC Basic Transl Sci. 2023 Jul 19;8(9):1215-1239
C57BL/6J female mice	DOX-induced bone loss model	Intraperitoneal injection	5 mg/kg	DOX once per week for three weeks; 3-MA daily for four weeks	Injection of 3-MA reversed DOX-induced bone loss and reduced the area of OCs on the bone surface.	Antioxidants (Basel). 2022 Jul 28;11(8):1476.
Mice	Heterotopic transplant model of intestinal fibrosis	Intraperitoneal injection	10 mg/kg	Once daily for 7 days	3-MA further inhibited autophagy in the grafted tissue and aggravated fibrosis.	Cells. 2019 Sep 13;8(9):1078
BALB/C nude mice	A2780 tumor xenograft model	Not specified	5 mg/kg	3 weeks	To investigate the effect of 3-MA on A2780 tumor growth, it was found that 3-MA could completely suppress autophagy induced by the combination of erlotinib and AZD2281 and attenuate its antitumor activity.	Drug Des Devel Ther. 2015 Jun 22;9:3183-90

细胞研究

细胞系	浓度	检测类型	检测时间	活性说明	数据源

1321N1	5mM	Cytotoxicity Assay	24h	protects cell against PCN-induced toxicity	23525265
95D	3mM	Growth Inhibition Assay	2h	reduces growth inhibitory effect of BDMC	25716561
95D	5mM	Apoptosis Assay	2h	inhibits BDMC-induced apoptotic cell death	25716561
A2780	5mM	Apoptosis Assay	24h	converts FTY720 with CDDP into an additive effect towards killing ovarian cancer cells	23592281
A2780cp	1mM	Growth Inhibition Assay	1h	increases cisplatin-induced cell death	25322694
A2780cp	2.5mM	Apoptosis Assay	1h	enhances cisplatin-induced cell death	24817946
A2780cp	2.5mM	Apoptosis Assay	1h	enhances cisplatin-induced cell death	24817946
A549	3mM	Growth Inhibition Assay	2h	reduces growth inhibitory effect of BDMC	25716561
A549	5mM	Apoptosis Assay	2h	inhibits BDMC-induced apoptotic cell death	25716561
A549	5mM	Function Assay	2h	suppresses SPC induced accumulation of LC3-II	25285628
A549	5mM	Apoptosis Assay	48h	decreases the percentage of cell death and expression levels of caspase-3, Beclin-1 and LC3-II	24706303
A549	10mM	Apoptosis Assay	48h	accelerates the reduction of cell viability induced by PTX	24626722
A549	10mM	Function Assay	4h	inhibits autophagy induced by irradiation	24142735
A549	0.1mM	Function Assay	24h	suppresses SU11274-induced cell death	22466960
ACHN-5968	5mM	Apoptosis Assay	3h	enhances paclitaxel-mediated apoptosis	24305604
BGC-823	5mM	Function Assay	2h	inhibits the rate of autophagic cells	22322152
ECSCs	10mM	Apoptosis Assay	4h	decreases rapamycin-treated apoptosis	24319109
GTL-16	5mM	Apoptosis Assay	24h	reduces cell viability as compared to cells treated with MET inhibitors	23313490
H1299	10mM	Function Assay	4h	increases cisplatin-induced cell death	24173208
H157	5mM	Function Assay	2h	suppresses SPC induced accumulation of LC3-II	25285628
H460	10mM	Function Assay	4h	increases cisplatin-induced cell death	24173208
HBx	10mM	Apoptosis Assay	48h	increases cell death	22020078
HCT116	5mM	Apoptosis Assay	24h	enhances the apoptosis induced by apigenin	24626522
HCT116	5mM	Apoptosis Assay	24h	enhances apigenin-induced cell death	24626522
HeLa	10mM	Function Assay	2h	suppresses LC3 II expressison	23864738
Hela	5mM	Function Assay	24h	inhibits starvation-induced autophagy	23395679
HeLa	10mM	Apoptosis Assay	2h	decreases cell viability co-treatment with PEI	23000135
HeLa	5mM	Apoptosis Assay	24h	induces caspase-dependent cell death	22545128
HeLa	2mM	Cytotoxicity Assay	24h	inhibites the cytotoxicity of silibinin to HeLa cells.	21875385
Hep3B	2mM	Apoptosis Assay	12h	inhibits AZD8055-induced cell death	24297300
Hep3B	5mM	Apoptosis Assay	24h	attenuates TNF-α protection against serum starvation-mediated apoptosis	24066693
HepG2	5mM	Function Assay	4h	increases HL release	24713587
HepG2	10mM	Function Assay	24h	inhibits siTIGAR- and HBSS-induced autophagy	23817040
HepG2	3mM	Apoptosis Assay	5h	reduces cell apoptosis induced by QDs	22836595
HepG2	5mM	Function Assay	4h	increases cellular levels of HL	24713587
HepG2	2mM	Apoptosis Assay	1h	enhances radiation-induced cell death	21453691
HepG2 E47	2.5mM	Function Assay	48h	increases the toxicity of AA, BSO, and CCl4	24273738
HGC-27	10mM	Function Assay	1h	inhibits the cell viability loss by RAD001 or MK-2206	24416349
HO8910	10mM	Apoptosis Assay	12h	enhances B19-induced apoptosi	23983610
HONE-1	5mM	Function Assay	1h	represses 6r-mediated ROS production	23892358
HT-29	1mM	Apoptosis Assay	48h	enhances bortezomib-induced cell viability loss	24842158
HT-29	1mM	Function Assay	48/96h	inhibits AMPK induces autophagic cell death	23508272
Huh7	2mM	Apoptosis Assay	12h	inhibits AZD8055-induced cell death	24297300
HUVECs	3mM	Function Assay	24h	blocks the protective effect of resveratrol by inhibiting autophagy	23358928
HUVECs	10mM	Function Assay	0.5h	decreases the AGE-BSAinduced autophagy leve	21468592
Jurkat	10mM	Function Assay	1h	decreases the expression of LC3-II and the formation of autophagosomes	21864037
K562	10mM	Function Assay	1h	decreases the expression of LC3-II and the formation of autophagosomes	21864037
LoVo	5mM	Apoptosis Assay	48h	enhances DCA-induced apoptosis.	24201812
Marc-145	5mM	Function Assay	12/24/36h	reduces the PRRSV titers and the protein expression	22119900
MCF7	5mM	Function Assay	24h	increases CuO induced cell death	23962629
MCF-7	10mM	Function Assay	24h	inhibits the autophagy induced by chemotherapy drugs	24315578
MCF-7	5mM	Function Assay	24h	inhibits starvation-induced autophagy	23395679
MCF-7	2mM	Function Assay	24h	inhibits autophagy induced by TM	24970676
MCF-7	2mM	Function Assay	48h	promotes TM-induced cell death	24970676
MCF-7	0.1mM	Apoptosis Assay	6h	enhances sirtinol-induced apoptosis	22751989
MCF-7	10mM	Function Assay	48h	blocks autophagy induced by bortezomib	21931937
MDA-MB 231	5mM	Apoptosis Assay	0.5h	modulates Tocomin® induced apoptosis	24830781
MDA-MB231	5mM	Function Assay	1h	increases resveratrol-mediated caspase activation and cell death	23088850
MDA-MB-231	2mM	Function Assay	24h	inhibits autophagy induced by TM	24970676
MDA-MB-231	2mM	Function Assay	48h	promotes TM-induced cell death	24970676
MDR	10mM	Apoptosis Assay	6h	strengthens the power of anticancer drugs	25019701
MG-63	0.5/1mM	Function Assay	48h	induces salinomycin-induced cell viability loss	24358342
MG-63	0.5/1mM	Apoptosis Assay	32h	enhances salinomycin-induced cell apoptosis	24358342
MG-63	10mM	Apoptosis Assay	12h	enhances DP-induced apoptosis	24358301
Microglia	5mM	Apoptosis Assay	24h	decreases hypoxia-induced cell death	24818601
Microglia	5mM	Apoptosis Assay	24h	decreases hypoxia-induced cell death	24818601
Nara-H	5mM	Growth Inhibition Assay	48h	enhances temsirolimusmediated suppression of Nara-H cell proliferation	21805033
NBL-W-S	1mM	Growth Inhibition Assay	6h	enhances GANT-61 toxicity	25323222
NBL-W-S	1mM	Apoptosis Assay	6h	increases cell apoptosis induced by GANT-61	25323222
NTUB1	5mM	Apoptosis Assay	1.5h	potentiates celecoxib-induced apoptosis	24349176
OR6	10mM	Function Assay	72h	suppresses HCV replication and formation of autophagosomes	23395875
OV2008	5mM	Apoptosis Assay	24h	converts FTY720 with CDDP into an additive effect towards killing ovarian cancer cells	23592281
PaCa44	2.5mM	Apoptosis Assay	1h	reduces genipin-mediated apoptosis	23124112
PANC-1	1mM	Apoptosis Assay	48h	enhances bortezomib-induced cell viability loss	24842158
PC12	10mM	Function Assay	24h	inhibits chymotrypsin-like proteasomal activity.	23603979
PC12/TetOn	0.1/1mM	Function Assay	18h	leads to α-syn(WT) accumulation, toxicity, and oligomer formation	21906659
PC-3	2mM	Apoptosis Assay	2h	increases ORI-induced cell death	22745580
pDCs	10mM	Function Assay	0.5h	reduces the induction of IFN-α by ssRNA40	22396599
RKO	2mM	Function Assay	1h	enhances cell death by geldanamycin	24291777
RMPI8226	5mM	Function Assay	1h	suppresses the level of autophagy under nutrient depletion	21915620
Saos-2	10mM	Apoptosis Assay	24h	intensifies the growth inhibition of the U2OS cells induced by Dox	24639013
Saos-2	1mM	Apoptosis Assay	96h	increases cell death induced by PCX	23563171
SGC-7901	2mM	Apoptosis Assay	1h	increases CA-4 induced apoptosis	24321340
SH-SY5Y	1mM	Function Assay	24h	inhibits the autophagy induced by TOCP	23743148
SH-SY5Y	5mM	Apoptosis Assay	1h	abolishes celastrol neuroprotective effect	23619395
SH-SY5Y	5mM	Cytotoxicity Assay	24h	increases PCN toxicity	23525265
SK-HEP-1	10mM	Apoptosis Assay	1h	protects against autophagy and induces apoptosis in bufalin-treated cells	22858649
SMMC-7721	2mM	Apoptosis Assay	1h	increases CA-4 induced apoptosis	24321340
SMMC-7721	5mM	Apoptosis Assay	24h	attenuates TNF-α protection against serum starvation-mediated apoptosis	24066693
T24	5mM	Apoptosis Assay	1.5h	potentiates celecoxib-induced apoptosis	24349176
T24	10mM	Function Assay	1h	reduces the cleavage of LC3 after baicalin treatment	23354080
T-47D	10mM	Function Assay	2h	inhibits autophagy process and increases rapamycin induced apoptosis	23300026
U251	5mM	Apoptosis Assay	24h	increases S1-induced cell death	22579788
U251MG	3mM	Function Assay	1h	suppresses LC3-II protein expression	23338618
U2OS	10mM	Apoptosis Assay	24h	intensifies the growth inhibition of the U2OS cells induced by Dox	24639013
U2OS	0.5/1mM	Function Assay	48h	induces salinomycin-induced cell viability loss	24358342
U2OS	10mM	Growth Inhibition Assay	24h	intensifies the growth inhibition induced by Dox	24639013
U937	2mM	Function Assay	12h	decreases the autophagy ratio	22155150
UOK257	5mM	Apoptosis Assay	3h	enhances paclitaxel-mediated apoptosis	24305604
WiDr	10mM	Function Assay	1h	inhibits PCBL-induced LC3 II expression	24190489

靶点	p110γ PI3Kγ, IC50:60 μM Vps34 Vps34, IC50:25 μM
描述	Vps34 is one kind of PI3K isoform, which plays an essential role in endosomal trafficking of proteins to the vacuole/lysosome, autophagy and phagocytosis. 3-Methyladenine (3-MA) shows inhibition of Vps34 in vitro, with an IC50 of 25 μM as compared with 60 μM for PI3Kγ. 3-Methyladenine is typically employed at a concentration of 10 mM in cellular studies^[1]. It is usually served as the inhibitor for both autophagy^[1] and type 1 mitophagy through suppression of class III PI3K activity ^[2]. However, now it was found that 3-Methyladenine play a dual role in modulation of autophagy. Prolonged treatment with 3-Methyladenine (5mM) up to 9 h can induce LC3 I to II conversion in wild type MEFs, L929 and 293T cells cultured in full-medium, whereas it is still effective in suppressing LC3 II conversation in cells induced by starvation. And this observation is consistent with result of punctuate formation of GFP-LC3 study. These results demonstrate that prolonged treatment with 3-Methyladenine under nutrient-rich conditions can enhance autophagic flux. This may due to its different temporal patterns of inhibition on Class I and III PI3K^[3].
作用机制	May due to the specific hydrophobic ring to Vps34 encircles the 3-methyl group of 3-MA.^[1]

Animal Administration	Rats: 15 mg/kg^[4] Mice: 35 mg/kg^[5]
Dose	Mice: 35 mg/kg^[5] Rats: 15 mg/kg^[4]
Administration	i.v., i.p.

CAS号	5142-23-4
分子式	C₆H₇N₅
分子量	149.15
SMILES Code	NC1=C2N=CN=C2N(C)C=N1
MDL No.	MFCD00010531

别名	3-甲基腺嘌呤 ;3-MA; NSC 66389; 3-Methyladenine, NSC 66389
运输	蓝冰
InChI Key	ZPBYVFQJHWLTFB-UHFFFAOYSA-N
Pubchem ID	135398661

3-Methyladenine/3-甲基腺嘌呤 {[allProObj[0].p_purity_real_show]}

3-Methyladenine/3-甲基腺嘌呤纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

3-Methyladenine/3-甲基腺嘌呤质控信息

3-Methyladenine/3-甲基腺嘌呤生物活性

3-Methyladenine/3-甲基腺嘌呤细胞实验

3-Methyladenine/3-甲基腺嘌呤动物实验

3-Methyladenine/3-甲基腺嘌呤动物研究

3-Methyladenine/3-甲基腺嘌呤参考文献

3-Methyladenine/3-甲基腺嘌呤实验方案

3-Methyladenine/3-甲基腺嘌呤技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

3-Methyladenine/3-甲基腺嘌呤 {[allProObj[0].p_purity_real_show]}

3-Methyladenine/3-甲基腺嘌呤 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

3-Methyladenine/3-甲基腺嘌呤 质控信息

3-Methyladenine/3-甲基腺嘌呤 生物活性

3-Methyladenine/3-甲基腺嘌呤 细胞实验

3-Methyladenine/3-甲基腺嘌呤 动物实验

3-Methyladenine/3-甲基腺嘌呤 动物研究

3-Methyladenine/3-甲基腺嘌呤 参考文献

3-Methyladenine/3-甲基腺嘌呤 实验方案

3-Methyladenine/3-甲基腺嘌呤 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

3-Methyladenine/3-甲基腺嘌呤纯度/质量文件产品仅供科研

3-Methyladenine/3-甲基腺嘌呤质控信息

3-Methyladenine/3-甲基腺嘌呤生物活性

3-Methyladenine/3-甲基腺嘌呤细胞实验

3-Methyladenine/3-甲基腺嘌呤动物实验

3-Methyladenine/3-甲基腺嘌呤动物研究

3-Methyladenine/3-甲基腺嘌呤参考文献

3-Methyladenine/3-甲基腺嘌呤实验方案

3-Methyladenine/3-甲基腺嘌呤技术信息